Corcept Therapeutics Incorporated (LON:0I3Q)
London
· Delayed Price · Currency is GBP · Price in USD 68.40
-3.38 (-4.71%)
At close: Jul 7, 2025
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of 5.63 billion as of July 11, 2025. Its market cap has increased by 127.29% in one year.
Market Cap
5.63B
Enterprise Value
5.21B
Revenue
530.53M
Ranking
n/a
PE Ratio
54.90
Stock Price
68.40
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from 154.68M to 5.63B, an increase of 3,539.77%. That is a compound annual growth rate of 18.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.45B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.38B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Indivior | 1.43B |